ProMetic is a publicly traded, global biopharmaceutical corporation that is comprised of a group of subsidiaries, specialized in the design of small molecules that mimic unique and specific interactions between proteins ProMetic's technologies are used to remove pathogens from blood, and extract and recover valuable proteins from plasma We are also developing our own novel therapeutics products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer, and autoimmune disease/inflammation as well as certain nephropathies